Assessment of hypoxic subvolumes in laryngeal cancer with 18F-fluoroazomycinarabinoside (18F-FAZA)-PET/CT scanning and immunohistochemistry. Issue 1 (October 2015)

• Record Type: Journal Article
• Authors: Bruine de Bruin, Leonie; Bollineni, Vikram R.; Wachters, Jan E.; Schuuring, Ed; van Hemel, Bettien M.; van der Wal, Jacqueline E.; Slagter-Menkema, Lorian; de Bock, Geertruida H.; Steenbakkers, Roel J.H.M.; Langendijk, Johannes A.; Pruim, Jan; van der Laan, Bernard F.A.M.; Halmos, Gyorgy B.
• Is Part Of: Radiotherapy and oncology. Volume 117:Issue 1(2015:Oct.)
• Page Start: 106
• Page End: 112
• Publication Date: 2015-10
• Subjects: Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/j.radonc.2015.07.012
• Languages: English
• ISSNs: 0167-8140

Abstract

<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background and purpose</title> <p id="sp0005"> <sup>18</sup>F-fluoroazomycinarabinoside (<sup>18</sup>F-FAZA) is a promising hypoxia radiopharmaceutical agent with outstanding biokinetic parameters. We aimed to determine the accuracy of <sup>18</sup>F-FAZA-PET/CT scan in detecting hypoxic regions within the tumor using immunohistochemical markers in a pilot study.</p> </sec> <sec> <title id="st015">Patients and methods</title> <p id="sp0010">Eleven patients with primary or recurrent laryngeal squamous cell carcinoma were indicated for total laryngectomy (TLE). Patients underwent <sup>18</sup>F-FAZA-PET/CT scan before TLE. Hypoxic regions inside the laryngeal tumor were determined. After TLE, regions with high uptake on <sup>18</sup>F-FAZA-PET scan were selected for immunohistochemical examination for exogenous (pimonidazole) and endogenous (HIF1α, CA-IX and GLUT-1) hypoxia markers. To assess the accuracy of <sup>18</sup>F-FAZA-PET scanning, radiopharmacon accumulation was related with immunohistochemical expression of hypoxia markers.</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">Inter- and intratumoral heterogeneity of tumor hypoxia was observed on <sup>18</sup>F-FAZA-PET scan. Nine of the eleven tumors were hypoxic with <sup>18</sup>F-FAZA-PET. Hypoxia could also be detected with pimonidazole, HIF1α, CA-IX and GLUT-1 expression in some tumors. No clear association was observed between <sup>18</sup>F-FAZA uptake and hypoxia markers.</p> </sec> <sec> <title id="st025">Conclusions</title> <p id="sp0020">This pilot study could not prove the accuracy of <sup>18</sup>F-FAZA-PET in determining hypoxic subvolumes in laryngeal cancer. Further study is required to investigate the benefit of <sup>18</sup>F-FAZA-PET imaging in radiotherapy planning.</p> </sec> </abstract>